By the mid-1970s the autoimmune origin of myasthenia gravis had been well established. Once this feat had been accomplished, it also became apparent that myasthenic disorders occurring in a genetic or congenital setting had a different etiology. As a result, a number of distinct myasthenic syndromes have been recognized and investigated by electrophysiological and ultrastructural methods. The newly recognized disorders are conditioned by divergent causes, such as a failure of acetylcholine resynthesis or packaging, absence of acetylcholinesterase from the neuromuscular junction, abnormal gating properties of the acetylcholine receptor-associated ion channel, or an abnormality in the regulation of the density of acetylcholine receptor molecules in the postsynaptic membrane. These genetic defects either impair neuromuscular transmission directly or result in secondary derangements that eventually compromise the safety margin of neuromuscular transmission. ( J Child Neurol 1988;3:233-246).
This review first considers the safety margin of neuromuscular transmission and then surveys the currently recognized congenital myasthenic syndromes.
The Safety Margin of Neuromuscular Transmission
In each myasthenic syndrome, the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. Therefore, a clear understanding of the concept of the safety margin is essential for grasping the pathogenesis of these syndromes. The factors that affect the safety margin are reviewed here briefly. For further discussion, the reader is referred to recent reviews on basic aspects of neuromuscular transmission and structures. [1] [2] [3] The neuromuscular junction (NMJ) consists of a nerve terminal separated from the postsynaptic region by the synaptic space. Acetylcholine (ACh) is stored in quantal packets (6, 000 to 10,000 molecules per packet) in synaptic vesicles in the nerve terminal. The vesicles release ACh into the synaptic space by exocytosis. The postsynaptic region contains junctional folds containing on their terminal expansions acetylcholine receptor (AChR) molecules packed at a density of about 10,000 sites per square micrometer. The binding of two ACh molecules to an AChR molecule opens the AChR ion channel, which subsequently closes again when ACh dissociates from AChR. Acetylcholinesterase (AChE) is distributed throughout the basal lamina of the synaptic space at a density of about 2,500 sites per square micrometer.
In the resting state, single ACh quanta are randomly released into the synaptic space. The high local ACh concentration saturates all nearby AChE sites so that most ACh molecules can reach postsynaptic AChRs. The AChR packing density is so high that ACh only needs to diffuse 0.3 pm along the top and 0.3 pm down along the junctional folds before it meets all the AChR it can saturate. The resultant resting depolarizations of the muscle fiber are known as miniature endplate potentials (MEPPs) . When ACh dissociates from AChR it is hydrolyzed by AChE to choline and acetate. Choline is taken up by the nerve terminal and is reutilized for ACh synthesis.
The MEPP amplitude depends on the number of ACh molecules in the quantum, the number of available AChRs, the geometry of the synaptic space, and the average depolarization generated by the opening of an AChR ion channel. The MEPP duration depends on the average channel open time, the functional state of AChE, and the cable properties of the muscle fiber surface membrane.
Depolarization of the nerve terminal by nerve impulse opens voltage-sensitive calcium channels in the presynaptic membrane. The calcium influx increases the probability of synaptic vesicle exocytosis, and exocytosis of numerous vesicles occurs adjacent to active zones in the presynaptic membrane. There is evidence to indicate that the voltage-sensitive calcium channels are associated with regularly arrayed large membrane particles in the active zones.
The quanta released by a nerve impulse generate an endplate potential (EPP). The EPP amplitude depends on the MEPP amplitude and the number of quanta released by nerve impulse (m). The value of m depends on the probability of release (p) and the number of quanta readily available for release (n), according to the relationship m = np. The safety margin of neuromuscular transmission is defined as the difference between the actual EPP amplitude and the EPP amplitude required to trigger the muscle fiber action potential.
Repetitive stimulation results in a frequencydependent depression of the EPP amplitude, and of the safety margin, to a certain plateau. The decrease is mainly due to a decrease in n. Repetitive stimulation also can facilitate transmitter release by increasing p, or n, or both. The temporal profiles of the opposing processes are such that (1) a defect of neuromuscular transmission is most readily detected by a train of 5 to 10 stimuli delivered at a low (2to 3-Hz) frequency and that (2) tetanic stimulation results in transient improvement and then a worsening of the defect.
Familial Infantile Myasthenia (FIM) Clinical Features
This disease presents in early infancy or childhood. The earliest symptoms are intermittent drooping of the eyelids (ptosis), poor suck and cry, secondary respiratory infections, and episodic crises precipitated by fever, excitement, or vomiting. During crises, all symptoms worsen; respiratory muscle weakness re-, sults in hypoventilation or apnea. If untreated, the crisis can be fatal or can produce anoxic cerebral damage. With increasing age, the crises become less frequent. After age 10 years, some patients complain only of easy fatigability on sustained exertion; others have mild to moderate weakness of cranial, limb, and respiratory muscles even at rest, resembling patients with mild to moderately severe autoimmune myasthenia gravis. The deep-tendon reflexes remain normally active, there is no loss of muscle bulk, and a permanent myopathy does not occur. The disease is transmitted by autosomal recessive inheritance. [4] [5] [6] [7] [8] [9] Electrophysiological aspects The electromyogram (EMG) may not show any abnormality in muscles that are not weak when examined. In the weak muscles one may detect the nonspecific features of neuromuscular transmission defects: (1) an abnormal fluctuation in the shape or size of the motor unit potentials during voluntary effort; (2) a progressive decrement in the amplitude of the compound muscle action potential evoked by repetitive, low-frequency (2-to 3-Hz) stimulation; (3) improvement of the decremental response immediately after a brief period of maximal voluntary exercise, followed within a minute by an increased decremental response ; and (4) single-fiber EMG abnormalities consisting of an abnormally prolonged interpotential interval between two muscle fibers in an activated motor unit (increased jitter), and failure of a proportion of the impulses to generate an action potential at one of the two fibers (blocking). In those patients whose muscles are not weak, the weakness and the EMG abnormalities can be induced in some, but not all, muscles either by exercise or by repetitive stimulation at 10 Hz for a few minutes. 10 The EMG decrement, when it is present, can be corrected by the cholinesterase inhibitor, edrophonium. ~ 6 In vitro studies by E. H. Lambert on external intercostal muscles have elucidated the electrophysiologic basis of the disorder. [10] [11] [12] Stimulation of small muscle bundles at 10 Hz resulted in an abnormal decrease of the amplitude of evoked compound muscle action potential ( Figure 1 ) and of the EPP. Unlike in autoimmune myasthenia gravis, the MEPP amplitude was normal in rested muscle but decreased abnormally after 10-Hz stimulation for 5 minutes. From these findings, one can infer that in FIM the safety margin of neuromuscular transmission is compromised by an abnormal decrease of the EPP due to an abnormal decrease of the MEPP.
The decrease of the MEPP amplitude in the course of prolonged stimulation from an initially normal to an abnormally low level suggests a progressive decrease in the amount of ACh released from synaptic vesicles. An alternative explanation might be an abnormal desensitization of postsynaptic AChR by physiologic amounts of ACh released in the course of stimulation. However, in that case cholinesterase inhibitors should worsen the defect, but in fact they improve it. The idea that synaptic vesicles become depleted of ACh during repetitive stimulation is further strengthened by the fact that the response of FIM muscle to electrical stimulation is like that of normal muscle exposed to hemicholinium,13-16 an inhibitor of choline uptake by the nerve terminal ( Figure 1 ). FIGURE 1 FIM. Effect of 10-Hz stimulation on the amplitude of the evoked compound muscle action potential in external intercostal muscle strips in vitro in two FIM patients (left panel) and in a normal subject (right panel). In the presence of 1 mg/dL of hemicholinium-3, the evoked action potential in normal muscle (open circles) declines as rapidly as the evoked action potential in FIM muscle in the absence of hemicholinium. (From Mora et a112 with permission). From these observations one can infer that FIM is caused by a defect in (1) the facilitated uptake of choline by the nerve terminal, (2) ACh resynthesis by choline acetyltransferase, or (3) the transport of ACh molecules into the synaptic vesicles.
Morphological Observations
Muscle biopsy specimens show no histochemical abnormality. In particular, the usual checkerboard distribution of histochemical fiber types is preserved. AChE-reacted sections demonstrate no abnormality of the NMJ. There are no immune complexes (IgG or complement) at the NMJ. The nerve terminals show normal immunoreactivity for choline acetyltransferase.9 This, however, does not exclude the possibility of a mutation that alters the kinetic properties of the enzyme.
On electron microscopy, the NMJ appears normal on simple inspection (Figure 2A ). There is no morphometric abnormality in the size or mitochondrial content of the nerve terminal, the postsynaptic area of folds and cleft, or the postsynaptic membrane length per unit area. Ultrastructural localization of AChR with peroxidase-labeled a-bungarotoxin shows normal abundance and distribution of AChR on the terminal expansions of the junctional folds ( Figure 2B ). Quantitative estimates of the length of the postsynaptic membrane reactive for AChR normalized for the length of the primary synaptic cleft (AChR index) and radioimmunochemical estimates of the AChR content of intercostal muscle are also normal.',l° . Recently, Mora, Lambert and Engel 12 searched for a morphologic correlate of the failure of neuromuscular transmission in FIM. In previous studies, Jones and Kwanbunbumpen14,15 showed that prolonged stimulation of the isolated rat diaphragm exposed to hemicholinium results in an abnormal decrease of the MEPP amplitude and of synaptic vesicle size. Thus, if in FIM the abnormal decrease of the MEPP amplitude on nerve stimulation was caused by impaired choline uptake by the nerve terminal, or by another defect in ACh synthesis, then the expected morphologic concomitant would be an abnormal decrease in synaptic vesicle size.
To test this notion, intercostal muscles from three FIM patients and three control subjects were studied before and after 10-Hz stimulation for 10 minutes. In the patients, but not in the controls, neuromuscular transmission failed during stimulation (Figure 1 ). FIGURE 2 FIM. Electron micrographs of NMJ regions in external intercostal muscle. The specimen shown in 2A was prepared for electron microscopy by conventional methods. The nerve terminal and postsynaptic region appear normal. T&dquo;ne specimen shown in 2B was incubated with peroxidase-labled a-bungarotoxin before fixation. The black reaction product for peroxidase on the terminal expansions of the junctional folds demonstrates a normal distribution of the acetylcholine receptor on the postsynaptic membrane. (2A, x 28,200; 2B, x 16,000.) Synaptic vesicle densities (numberhlm2) and diameters were separately analyzed in a superficial 200nm-wide zone adjacent to the presynaptic membrane, where vesicles are positioned for release, and in the remaining deeper part of the nerve terminal from which vesicles may be mobilized for release. In both patients and controls, stimulation had a similar effect on the density of the superficial and of the deep synaptic vesicles, decreasing the former by 20% and the latter by 30% to 50% below the initial value. For a given site, synaptic vesicle densities did not differ significantly between patients and controls either before or after stimulation. However, unexpectedly, the size of the synaptic vesicles was significantly smaller EFFECT OF STIMULATION ON SYNAPTIC VESICLE VOLUME in rested FIM than control muscles. Further, after stimulation, when the MEPP amplitude was markedly reduced in FIM, the FIM vesicles increased or did not change size. By contrast, after stimulation the control synaptic vesicles decreased or did not change in size (Figure 3 ).
There is no simple explanation for the lack of correlation between synaptic vesicle size and the MEPP amplitude in FIM. From current knowledge derived from studies of synaptic vesicles in the Torpedo electric organ, ACh is taken up by the synaptic vesicles by a proton-driven ACh translocase that exchanges protons in the vesicles for cytosolic ACh. 17 voluntary muscles from birth. The symptoms are refractory to anticholinesterase drugs and cause severe disability. Conventional histologic studies of muscle specimens are normal. The basic abnormality is total absence of AChE from the NMJ: no enzyme activity can be demonstrated by light microscopic or electron microscopic cytochemistry (Figure 4 ), and no immunoreactivity for AChE is detected by polyclonal and several monoclonal AChE antibodies.9 The total muscle AChE content is also reduced.
Because AChE is absent from the NMJ, ACh-AChR interaction and the duration of the EPP and MEPP are prolonged. Because the amplitude of the prolonged EPP remains above the threshold required for firing the muscle fiber action potential when the fiber recovers from the refractory period of the preceding action potential, one long EPP can evoke two or more muscle fiber action potentials. Consequently, a single supramaximal stimulus applied to a motor nerve can evoke two or more compound muscle action potentials.
The motor nerves are abnormally small ( Figure   5A and B) and contain a reduced number of releasable FIGURE 4 Electron cytochemical localization of AChE in congenital endplate AChE deficiency. In 4A, control endplate is greatly overreacted after incubation for 30 minutes at room temperature. Here, the black reaction product (lead sulfide) completely covers the synaptic space and junctional folds and has spread into adjacent regions. In ( Figure 5B ) or reduceds at the NMJ. The AChR loss, when present, is caused by degenerative changes in the junctional folds, which can be accounted for by the ACh excess .12-&dquo; However, the ACh excess is mild because ACh release is limited by the small size of the nerve terminals. The safety margin of neuromuscular transmission is compromised by lack of releasable ACh quanta and, to a lesser extent, by AChR deficiency.
Slow Channel Syndrome
Clinical Features This syndrome was described in 1982.25 Since then, one additional report has been published by Oosterhuis et al in 1987.26 The disease is transmitted by an autosomal dominant gene with high penetrance and variable expressivity. Sporadic cases also occur. The age of onset, the initial and eventual pattern of muscle involvement, the rate of progression, and the degree of weakness and fatigability vary from case to case. The disease may present in infancy, childhood or adult life. It progresses gradually or in an intermittent manner, remaining quiescent for years or decades between periods of worsening. Typically, there is selectively severe involvement of cervical, scapular, and finger extensor muscles (Figures 6 and 7) ; mild to moderate weakness of the eyelid elevators and limita- FIGURE 5 Congenital endplate AChE deficiency. In 5A, a small nerve terminal, almost completely surrounded by a Schwann cell (S), is applied against a small fraction of the postsynaptic region. The Slow channel syndrome, father (above) and son (below). Note atrophv of shoulder and forearm muscles and lordotic stance. (From Engel et al 25 with permission). Slow channel syndrome. Patient attempting to extend wrists and fingers as shown by examiner (with sleeve). Note atrophy of patient's forearm muscles. (From Engel et al2s with permission).
Electrophysiological Aspects
As in congenital endplate AChE deficiency, singlenerve stimuli evoke repetitive compound muscle action potentials in all muscles (Figure 8 , upper left panel). The consecutive potentials occur at 5to 10msec intervals, each smaller than the preceding one, and disappear after a brief voluntary contraction. Two nerve volleys 1 to 3 msec apart increase rather than inhibit the amplitude of the second action potential, indicating that it is not produced by an axon reflex.
A decremental EMG response at 2to 3-Hz stimulation is present, but only in clinically affected muscles (Figure 8 , upper right panel). The motor unit potentials fluctuate in shape and amplitude during voluntary activity.
In vitro microelectrode studies indicate that the duration and half-decay time of the intracellularly recorded MEPP (Figure 8 , lower panels) and EPP are markedly prolonged (about threefold) in all muscles, and the duration of the potentials is further increased by AChE inhibitors. The amplitude of the MEPP is significantly reduced in some but not all muscles, and the decrease is greater in the more severely affected muscles. The quantal content of the EPP is in the normal range. That the prolonged duration of the MEPP and EPP is not due to an alteration in the cable properties of the muscle membrane has been demonstrated by two measures: (1) the duration of the extracellularly 
Morphological Observations
Light microscopic histochemical studies show type 1 fiber predominance, isolated or small groups of atrophic fibers of either histochemical type, tubular aggregates, and vacuoles in fiber regions near motor endplates. Other biopsy specimens show abnormal variation in fiber size, variable fiber splitting, and, in some instances, mild to moderate increase of endomysial or perimysial connective tissue. AChE activity is present at all endplates. The configuration of the endplates is often abnormal, with multiple, small, discrete regions dispersed over an extended length of the muscle fiber. This finding is more pronounced in the more severely affected muscles. Focal calcium deposits were demonstrated at the endplates by Engel et a 121 in one of four cases in which this test was performed.
On electron microscopic examination, at many NMJs the junctional folds contain myriad pinocytotic vesicles and labyrinthine membranous networks. The junctional folds are frequently degenerating, causing widening of the synaptic space and accumulation of electron-dense debris (Figure 9 ). Some of the highly abnormal postsynaptic regions are denuded of their nerve terminals (Figure lOB ). Unmyelinated nerve sprouts appear near some NMJs. The intramuscular nerves are normal. There are no immune complexes (IgG or complement) at the NMJs. AChR is reduced at the NMJ, and especially in the more severely affected muscles.
The junctional sarcoplasm often contains membrane-bound vesicles which arise from dilations of the sarcoplasmic reticulum or from the outer membrane of nearby nuclei. In some regions the vesicles are intermingled with small dense bodies, swollen or degenerating mitochondria, myeloid structures and small vacuoles containing degraded membranous organelles. Fiber regions adjacent to endplates often contain tubular aggregates, irregularly arrayed tubules and vesicles, myeloid structures ( Figure 10A ), degenerating nuclei ( Figure 10B ), and proliferating Golgi elements and transverse tubular system networks. Deeper fiber regions show focal decreases in mitochondria and focal myofibrillar degeneration ( Figure 10B ). In some muscle fibers there are larger vacuoles near the endplate ( Figure 10B ). These contain amorphous or granular material or fragmented membranes and are limited by membranes of transverse tubular origin or by proliferating transverse tubular system networks.
Morphometric reconstruction of the endplate shows a 29% to 43% decrease of nerve terminal size and a 25% to 37% increase in synaptic vesicle density. The ,postsynaptic membrane length and density are significantly reduced due to degeneration of the junctional folds.
Biochemical Studies of AChE Although AChE inhibitors further increased the duration of the MEPP in vitro, and although AChE was present at the endplates by cytochemical criteria, a partial deficiency or kinetic abnormality of AChE could still account for the prolonged MEPP. This possibility was excluded by demonstrating that the activity and Km of AChE were normal in muscle in this syndrome.25 Since the catalytic subunit in all forms of muscle AChE is identical '28 the kinetic properties of total muscle AChE are a valid measure of the kinetic properties of endplate AChE.
Pathogenetic Mechanism
The prolonged EPP can be attributed to the prolonged MEPP. Since AChE is intact by physiological, histochemical and biochemical criteria, and since the prolonged MEPP cannot be attributed to abnormal cable properties of the muscle fiber plasma membrane, the As in congenital endplate AChE deficiency, the repetitive muscle action potential can be explained by the prolonged EPP. The fact that the repetitive muscle action potential response is present in all muscles indicates that the AChR ion channel abnormality is ubiquitous and represents the primary disturbance. Thus, the weakness, wasting, and fatigability that appear in selected muscles at variable intervals are secondary phenomena.
The prolonged endplate currents result in an ab-normally increased cation flux into the junctional folds and nearby muscle fiber regions. Because a fraction of the current is carried by calcium,29-'1 transient or permanent calcium excess is likely to occur in the junctional folds and nearby fiber regions. The deleterious effects of the focal calcium excess, which include activation of intracellular proteases and stimulation of membrane-bound phospholipases,32,33 can readily explain the focal degeneration of the junctional folds and the spectrum of myopathic changes observed in the junctional sarcoplasm and nearby fiber regions. Further, some of the findings are similar to those FIGURE 10 Slow channel syndrome. In 10A, muscle fiber region near NMJ displays numerous dilated vesicles of the sarcoplasmic reticulum and occasional myeloid structures. Few dilated components of the sarcoplasmic reticulum also appear between the myofibrils. In 10B, a highly degenerate postsynaptic region denuded of its nerve terminal (asterisk) overlies a fiber region that shows loss of mitochondria, focal myofibrillar degeneration, a disintegrating nucleus (N), and a large, membrane-bound vacuole (V). 10A is from infraspinatus muscle; 10B is from finger extensor muscle. (From Engel et al25 with permission). noted in mouse muscle exposed to carbachol, a cholinergic agonist, and the carbachol-induced changes can be prevented by exclusion of calcium from the extracellular fluid. 34
The focal degeneration of the junctional folds readily explains the loss of AChR from the folds. In addition, it is also possible that AChR synthesis is inhibited, as in cultured muscle exposed to cholinergic agonists . 35 One can infer that the AChR deficiency accounts for the reduced MEPP amplitude and the impaired safety margin of neuromuscular transmission.
The AChR ion channel is also slow in noninnervated muscle fibers and at newly formed endplates.36
It is therefore possible that the abnormality in the slow channel syndrome stems from a developmental failure of the slow-to-fast conversion of the ion channel. It is now know that this conversion is associated with a replacement of the gamma subunit of AChR by an epsilon subunit.31-3' Therefore, expression of the gamma instead of the epsilon subunit in slow channel syndrome AChR would be evidence for abnormal developmental regulation. A more plausible explanation at this time is that a mutation in a structural gene has so altered endplate AChR that its return from the open to the closed conformation is hindered.
Congenital Endplate AChR Deficiency
This syndrome is less well characterized and more heterogeneous than the preceding syndromes.
In three patients described by Vincent et al in 1981,4° NMJ AChE was preserved, and endplate currents were not abnormally long. NMJ AChR, estimated from the number of a-bungarotoxin binding sites, was reduced. In these patients, the AChR deficiency could be due to decreased synthesis, reduced membrane insertion, or accelerated degradation of AChR. In a patient investigated by Lecky et al in 1986,41 the NMJ appeared elongated on light microscopy, but NMJ ultrastructure was normal. The number of NMJ a-bungarotoxin binding sites was markedly reduced. No electrophysiological studies were done in this case.
In another patient studied by Vincent et al, 40 the amount of a-bungarotoxin bound to the NMJ was reduced only after prolonged washing. This may indicate a reduced affinity of AChR for a-bungarotoxin and, by inference, for ACh. In these patients, the muscle biopsy did not reveal a myopathy.
In another patient with a congenital myasthenic syndrome, endplate AChR deficiency and a small MEPP amplitude were associated with a severe my-opathy (E. H. Lambert, MD, and A. G. Engel, MD, unpublished data, 1982).
In two other patients with congenital contractures, NMJ AChR deficiency and small MEPPs were associated with poorly developed junctional folds. 42A3 Partially Characterized Congenital Myasthenic Syndromes AChR Deficiency and Increased Affinity for d-Tubocurarine A patient studied by Morgan-Hughes et a144 showed a slight decrease in NMJ AChR and a tenfold increase in the affinity of AChR for d-tubocurarine. The manner in which the latter abnormality contributed to the defect of neuromusclar transmission was not defined.
Decreased MEPPAmplitude Without A ChR Deficiency
In a patient studied by Vincent et al, 40 the MEPP amplitude was low, but the AChR content of the NMJ was normal. This could be due to decreased conductance or open time of the AChR ion channel, decreased number of ACh molecules per quantum, or reduced affinity of AChR for ACh. Specific studies to distinguish between these possibilities were not carried out. In a patient investigated by Lecky et at 41 a reduced MEPP amplitude was associated with normal a-bungarotoxin binding to the postsynaptic membrane, endplate structure, d-tubocurarine affinity, ion channel properties, and passive membrane properties ; the effectiveness of ACh to open ion channels, however, was reduced.
Possible Defect in ACh Synthesis, Mobilization or Storage
In one infant with a congenital myasthenic syndrome there was marked EMG decrement at all stimulation frequencies and moderate to marked facilitation 15 seconds after 50-Hz stimulation. Single-nerve stimuli did not evoke repetitive compound muscle action potentials and AChE and AChR were normally abundant at the NMJ. Ultrastructural studies of the NMJ suggested a slight decrease in the mean synaptic vesicle diameter. Anticholinesterases and guanidine were ineffective. Although in vitro electrophysiologic studies of neuromuscular transmission were not carried out, the observations were thought to be consistent with a defect in ACh synthesis, moblization or storage Familial Limb-Girdle Myasthenia This is an autosomal recessive syndrome. 46-48 Weakness of limb-girdle muscles and easy fatigability appear during childhood or in the teens. Ocular and other cranial muscles are not affected. The symptoms respond to anticholinesterase drugs but not to prednisone. EMG studies show a decremental response. Joint contractures, cardiac repolarization defect, type 1 fiber atrophy, and abnormal electrical irritability of the muscle fibers were also noted in one family.48
Histochemical studies demonstrated tubular aggregates in the muscle fibers, but the position of the aggregates relative to the NMJs was not established.
Detailed morphologic studies of the NMJ, in vitro electrophysiologic studies of neuromuscular transmission, and measurements of NMJ AChR are not available in this syndrome.
